SCHEMBL664566

SCHEMBL664566

c1cc2c(s1)CC[N]C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3576480 0.87 PNMT (0.41)
SCHEMBL739623 0.82
SCHEMBL6363449 0.78
SCHEMBL828997 0.65
SCHEMBL75265 0.65
SCHEMBL2485508 0.64 PNMT (0.48)
SCHEMBL15281530 0.64 PNMT (0.48)
SCHEMBL15278765 0.64 PNMT (0.48)
SCHEMBL23867 0.64 TSHR (0.46)
SCHEMBL15276726 0.64 PNMT (0.48)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240139182-A1 Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor HUTCHISON MEDIPHARMA LTD (CN) 2024-05-02 US claimed
US-20210154192-A1 CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR HUTCHISON MEDIPHARMA LIMITED (CN) 2021-05-27 US claimed
US-20180263977-A1 CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR HUTCHISON MEDIPHARMA LIMITED (CN) 2018-09-20 US claimed
US-20150141410-A1 GPR17 Receptor Modulators UNIVERSITA' DEGLI STUDI DI MILANO (IT) 2015-05-21 US claimed
US-8987269-B2 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor HUTCHISON MEDIPHARMA LIMITED (CN) 2015-03-24 US claimed
EP-2519524-A1 CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR Hutchison Medipharma Limited (CN) 2012-11-07 EP claimed
US-20120264739-A1 CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR HUTCHISON MEDIPHARMA LIMITED (CN) 2012-10-18 US claimed
WO-2011079804-A1 CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR HUTCHISON MEDIPHARMA LIMITED (CN) 2011-07-07 WO claimed
US-20070196504-A1 PHARMACEUTICAL COMPOSITION DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2007-08-23 US claimed
US-20040022848-A1 Medicinal composition DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-02-05 US claimed
EP-1319399-A1 MEDICINAL COMPOSITION DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-06-18 EP claimed
US-20240139182-A1 Certain Triazolopyridines and Triazolopyrazines, Compositions Thereof and Methods of Use Therefor HUTCHISON MEDIPHARMA LTD (CN) 2024-05-02 US disclosed
US-11896592-B2 Certain triazolopyridines and triazolopyrazines, compositions thereof and methods of use therefor HUTCHISON MEDIPHARMA LIMITED (CN) 2024-02-13 US disclosed
EP-3795573-B1 CERTAIN TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR HUTCHISON MEDIPHARMA LTD (CN) 2022-07-06 EP disclosed
US-20210154192-A1 CERTAIN TRIAZOLOPYRIDINES AND TRIAZOLOPYRAZINES, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR HUTCHISON MEDIPHARMA LIMITED (CN) 2021-05-27 US disclosed
US-20050152975-A1 Pharmaceutical composition DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2005-07-14 US disclosed
US-20040022848-A1 Medicinal composition DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2004-02-05 US disclosed
EP-1319399-A1 MEDICINAL COMPOSITION DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2003-06-18 EP disclosed
EP-1161956-A1 MEDICINAL COMPOSITIONS DAIICHI PHARMACEUTICAL CO., LTD. (JP) 2001-12-12 EP disclosed
WO-1997049397-A1 NOVEL MEDICINAL COMPOSITIONS OF HYDROPYRIDINES SANKYO COMPANY, LIMITED (JP) 1997-12-31 WO disclosed